One limit to succesdl receptor-mediated gene delivery is the exit of the endocytosed material from the endosome. We demonstrate here the delivery of marker genes to tissue culture cells using a modification of the receptormediated gene delivery technique that exploits the endosomolytic activity ofdefective adenovirus particles. In particular, >90% of the transfected-cell population is found to express a (-galactosidase gene, and, most importantly, this hig level of expression can be obtained with psoralen-inactivated virus particles. Furthermore, because the delivered gene is not carried within the genome of the adenovirus particle, the size constraints are relieved, and we can, therefore, show the delivery of a 48-kilobase cosmid DNA molecule.
We are developing methods of introducing DNA into mammalian cells with the goal of generating a safe and reliable method that introduces both small and large DNA into a high percentage ofthe target cells. Our strategy has been to exploit the receptor-mediated endocytosis route to deliver DNA. This approach uses various polycation-ligand chemical conjugates, such as transferrin-polylysine (1) (2) (3) (4) (5) , which serve to condense the DNA to be transferred into compact, ligandcoated toroids, comparable in size to a typical DNA virus (6). These ligand-coated DNA particles can then bind to receptors on the surface of target cells, and upon endocytosis, the DNA finds its way into the nucleus.
We have demonstrated both transient and stable gene delivery into a variety of cell types. In certain cell lines, such as K-562 cells, we can show transient gene expression in >90% of the target cells (5) . Stable expression of introduced genes can also be demonstrated, with up to 0.5-1% of the initial transfected-cell population recoverable as stable expressing clones (unpublished results).
We suspected that one of the major limits to gene delivery by endocytosis in many cell types may be the exit of the endocytosed material from the endosome. However, many viruses are known to enter cells via a similar receptormediated endocytosis route and possess molecular skills to mediate disruption of the endosomes to enter the cytoplasm of host cells. We have previously found that this endosomolytic activity ofa virus can function in trans to facilitate the coentry of receptor-bound DNA particles (7) . Plasmid DNA containing a marker gene is complexed and condensed into a compact parcel with polylysine covalently linked to a cellbinding ligand, such as transferrin. When these ligand-coated DNA donuts are supplied to the appropriate cells in the presence of a replication-defective adenovirus, both the DNA complex and the virus are endocytosed, and the low-pH-triggered adenoviral endosome disruption allows efficient cellular entry of the DNA (Fig. 1 ). This maneuver enhances delivered gene expression 100-to 1000-fold in a variety of cell types (7, 8) .
We present evidence here that when the target cell displays receptors for both the DNA-bound ligand (transferrin) and adenovirus, a very high percentage (>90%) of the target cells take up and express the marker gene. This trans application of virus solves many of the safety and practical problems associated with using recombinant viruses to deliver genes. In our system, the virus is functioning merely as an endosomolytic agent, and because virus gene expression is not required, we can use a transcription-and replication-defective virus. Most importantly, because the endosomolytic activity ofthe virus is probably a function ofthe virus protein capsid, we find that we can treat the virus with various agents that damage the nucleic acid of the virus while sparing the protein component, such as short-wave UV radiation or the DNA intercalator psoralen plus long-wave UV, and the DNA-delivery activity ofthe virus is largely retained. These inactivation protocols further block virus gene expression and replication. Because the virus particle is functioning in trans and the DNA to be delivered is not incorporated within the virus capsid, this system allows great size and sequence variety in the DNA to be delivered; in contrast to the 6-to 8-kilobase (kb) size limit of the standard recombinant adenovirus vectors (9), we routinely deliver 15-kb rounds of isopycnic banding on CsCl, as described (5) . HeLa, mouse hepatocyte BNL CL.2, and human neuroblastoma GI-ME-N cells (10) were grown in Dulbecco's modified Eagle's medium (DMEM)/2 mM glutamine/streptomycin at 10 ug/ml/penicillin at 100 units/ml/10% fetal calf serum (FCS) (DMEM+10%FCS).
Preparation of Adenovirus d1312. Adenovirus d1312, a replication-defective strain of human adenovirus 5 lacking functional Ela sequences (11) , was propagated on the complementing cell line 293 (12) as described (7) . Virus was isolated by two rounds of CsCl density-gradient purification, diluted with an equal volume of glycerol, and stored at -70TC. Viral titers were determined by end-point dilution, cytopathic effect (CPE) assay on 293 cells (13) , by UVabsorbance measurement of extracted viral DNA [using the relationship 1 absorbance unit at 260 nm (A260) equals 1012 viral particles per ml] (14) and by protein content (using the relationship 1 mg of viral protein = 3.4-3.5 x 1012 virus particles) (15) .
Preparation of Luciferase Cosmid (CosLuc). A 3.0-kb Sal I fragment, containing a single Photinus pyralis luciferasecoding sequence under the control of the Rous sarcoma virus promoter, was isolated from the plasmid p22ORSVLuca and ligated into the unique Sal I site of the cosmid clone C1-7aA1 (provided by A. Weith, Vienna) to form concatemers. Cl7aAl comprises a 37-kb human genomic DNA Sau3A fragment (partial digest), encoding no apparent genes, cloned into the BamHI site of the cosmid vector pWE15 (Stratagene). The ligation reaction was then packaged in vitro, and an aliquot of the resulting phage particles were infected into Escherichia coli NM554 and plated on LB ampicillin plates. The recombinants were screened by colony hybridization using the 3.0-kb Sal I fragment (32p labeled by random priming) as a hybridization probe, and a number of positives were analyzed by restriction mapping. A cosmid construct (CosLuc) containing a single copy of the Sal I insert was grown and purified on a CsCl gradient (total size = 48 kb).
The small control cosmid pWELuc (12 kb) was prepared by digesting CosLuc with Not I, religating, transforming bacteria, and isolating a clone containing the appropriate plasmid.
This procedure resulted in a 12-kb DNA molecule lacking the human DNA insert and part of the polylinker of CosLuc 1.
The plasmid clone pSPNeoLuc (8 kb) was obtained by ligating the 3.0-kb Sal I fragment from p22ORSVLuca described above into the Sal I site ofpSPNeo, a vector prepared by ligating a Xba I-Asp-718/Klenow blunt-ended fragment containing the polylinker of Bluescript M13 + into the Xba I and BamHI/S1 nuclease blunt-ended sites ofpSSTneoA. The plasmid pSSTneoA is the large Sst I fragment from pUCplocus (16) .
Transfection Protocols. In general, 6 pug ofDNA was diluted in 330 1.l of HBS (20 mM Hepes/150 mM NaCl, pH 7.4) and a sample of hTfpL, mTfpL, AfpL, or (gal)4pL (equivalent to 4 jig of polylysine) was diluted with 170 pl of HBS. The two solutions were mixed and allowed to incubate at room temperature for 30 min. One ml of DMEM/2%FCS was then added to the mixture followed by a sample of the adenovirus (quantities are specified in the figure legends). The medium was removed from a 6-cm dish of cells (grown to :'-80%o confluence) and replaced with the DNA/hTfpL/adenovirus mixture. After a 1-hr incubation at 37°C, 4 ml of DMEM+ 10%oFCS was added to the dish. Transfections using chloroquine contained 100 ,uM chloroquine during a 4-hr exposure to the DNA/conjugates, after which the cells were washed into fresh 10%o FCS-containing medium. After a 24-hr incubation at 37°C, the cells were harvested for luciferase assay (5 (Fig. 2A) , and there is only a slight improvement when transfection is done with 100 ,uM chloroquine (Fig. 2B) . However, >90% of the cells stain positive when the transferrinfection is done with adenovirus (Fig. 2C) (Fig. 2D) or mTF pL (Fig. 2E) and a neuroblastoma line GI-ME-N (data not shown). Psoralen-inactivated adenovirus (see below)
provides DNA-delivery augmentation similar to that obtained with nontreated adenovirus d1312 (Fig. 2F) . Note, . In all samples the virus particle-to-cell ratio was 5,000-10,000:1.
however, that a certain cell toxicity (the presence of small, dark, rounded cells) is associated with high-level DNA delivery in the HeLa cells (Fig. 2C) , and this toxicity can be partially relieved by psoralen treatment of the virus (Fig. 2F) . Augmentation of Delivery Involving Other Receptor-Ligand Pairs. Does the adenovirus augmentation occur with other receptor/ligand systems? Successful receptor-mediated gene delivery to hepatocytes has been obtained using asialoglycoprotein-polylysine conjugates that bind to the liverspecific asialoglycoprotein receptor (24, 25). We have developed a completely synthetic, galactose-containing, polylysine conjugate that presents as the receptor-recognition signal a cluster of four lactose moieties attached to a synthetic, branched linker peptide (E.W., unpublished results), which serves to target DNA delivery to hepatocytes. We tested the adenovirus-delivery enhancement of DNA delivered with this synthetic ligand [(gal)4pL] as well as a natural asialoglycoprotein receptor ligand (AfpL) and mTfpL.
These three different ligand polylysine conjugates were tested for DNA delivery into the mouse hepatocyte line BNL CL.2 (Fig. 3) . Delivery was tested in the absence of an endosomolytic agent (bars 1, 4, 7), in the presence of 100 puM chloroquine (bars 2, 5, 8), and in the presence of adenovirus d1312 particles (bars 3, 6, 9). We find very little delivery with any conjugate in the absence of chloroquine, modest delivery in the presence of chloroquine, and a very robust enhancement with all three conjugates in the presence of adenovirus.
Hence, the DNA-delivery enhancement observed with DNA delivered with transferrin-polylysine conjugates is not unique for the transferrin receptor. Adenovirus can also function to augment delivery into hepatocytes by using both synthetic [ (Fig. 4A ). Thus, it is possible to inactivate viral-replication functions without seriously impairing the endosome disruption activity. We sought a greater decrement in viral titer with less damage to the protein component. The psoralens are a class of small, hydrophobic molecules that can readily diffuse into intact virus particles and intercalate into the nucleic acid. Upon irradiation at 365 nm, the compounds form a covalently crosslinked structure that interferes with both transcription and replication reactions (26) . Psoralen treatment followed by 365-nm UV irradiation has proven to be an effective means of inactivating a variety of both enveloped and nonenveloped virus contaminations in various blood protein preparations while generating only a modest inactivation of the active protein component in the preparation (27-29). The DNA in intact adenovirus virions has been shown to be accessible to and capable of being crosslinked with psoralen (30) .
We treated purified adenoviral samples with 8-methoxypsoralen followed by 10 or 30 min of 365-nm UV light. The unbound 8-methoxypsoralen was then removed by gel filtration, and the adenovirus preparations were assayed for viral titer (by cytopathic effect assay on 293 cells) and for their ability to support luciferase-DNA delivery. We find 8-methoxypsoralen exposure coupled with 10 min of 365-nm UV generates a 4-logarithm drop in virus titer; when 8-methoxypsoralen exposure is coupled with 30-min UV exposure, a >5-logarithm drop is generated, and this is accompanied by only a 2-to 3-fold drop in luciferase-DNA-delivery activity (Fig. 4B) (9, (33) (34) (35) . The parvovirus constructs have a strict 5-kb capacity (36-38).
The size of polycation-condensed DNA particles shows a curious feature, in that the final size of the particle is relatively insensitive to the size of the DNA molecule used (39) (40) (41) (Fig. 5A, bar 2) , whereas the small plasmid is delivered successfully into these cells (Fig. 5A, bar 1 (7, 8) . We have explored here some of the additional features of the adenovirus augmentation. We find that transient transfection efficiencies approaching 100%o can be obtained when a chromogenic marker gene is introduced with this technique.
We have explored the variety of receptors that can be cointernalized with the adenovirus receptor and are, thus, amenable to the augmentation effect. We also find that DNA delivery with conjugates that bind the asialoglycoprotein receptor ( Fig. 3) and conjugates that bind CD4 can also be enhanced with adenovirus treatment (M.C., unpublished results). Although this is only a test sample of three different receptors, this work suggests that internalized receptors reach a common endosomal pool. The limit will now be the expression of the adenovirus receptor of the target cells. However, additional strategies linking the adenovirus particle to the polylysine-ligand/condensed DNA have been developed (44, 45 
